|
« Obama administration enlarges ethanol industry trough | Weblog | U.N. Climate panel pummeled for misinformation, high and low » Bisphenol baloney takes another hitBy Michael FumentoIn a provocatively entitled paper in the current issue of the prestigious journal Toxicological Sciences, Richard M. Sharpe asks "Is It Time to End Concerns over the Estrogenic Effects of Bisphenol A?" In a word, "yes." Bisphenol A, or BPA, is an incredibly valuable chemical added to plastics like baby bottles to make them harder and stronger. It's been in use for many decades. And the greens want to get rid of it because they say it's dangerous. Yet as I wrote recently in Investor's Business Daily,"Countries that have evaluated BPA in the last three years, as Trevor Butterworth of the STATS think tank has documented, include Norway, France, Germany (twice), Australia, New Zealand and Japan. Add to that a World Health Organization collaborative center. Each has found BPA safe." (CEI's Angela Logomasini also recently wrote an excellent paper on BPA safety.) But: The lynch mob is after BPA because it's a weak synthetic estrogen. These chemicals have been under fire since the publication of the 1996 book "Our Stolen Future," which one review aptly described as "an alarmist tract with a polemical style clearly crafted for its political, not scientific, impact." (With a foreword by Al Gore, no less.) And so we keep throwing massive amounts of money to scientists to study it more and study it more and study it more. Recently National Institute of Environmental Health Sciences Director Linda Birnbaum announced $30 million in grants for two more years of BPA research, using money from the stimulus act, to "address many of the research gaps" regarding the chemical. Yet over 5,400 medical journal articles have already been published on BPA safety. How many gaps can that leave? Sharpe comments on poorly done initial studies by an environmental aspect that I described, then writes: Fundamental, repetitive work on bisphenol A has sucked in tens, probably hundreds, of millions of dollars from government bodies and industry which, at a time when research money is thin on the ground, looks increasingly like an investment with a nil return. All it has done is to show that there is a huge price to pay when initial studies are adhered to as being correct when the second phase of scientific peer review, namely, the inability of other laboratories to repeat the initial studies, says otherwise. At some point it's time to say "Enough!" and we passed that point with BPA a long time ago. February 15, 2010 05:17 PM ·
Cancer
~ Chemophobia
~ Diseases (other than AIDS and cancer)
~ Environment
· Recent Posts
|
Syndication FeedsRSS 1.0RSS 2.0 Atom RSD Categories
ArchivesJuly 2010June 2010 May 2010 April 2010 March 2010 February 2010 January 2010 December 2009 November 2009 October 2009 September 2009 August 2009 July 2009 June 2009 May 2009 April 2009 February 2009 December 2008 September 2008 May 2008 April 2008 March 2008 February 2008 January 2008 December 2007 November 2007 October 2007 September 2007 August 2007 July 2007 June 2007 May 2007 April 2007 March 2007 February 2007 January 2007 December 2006 November 2006 October 2006 September 2006 August 2006 July 2006 June 2006 May 2006 April 2006 March 2006 February 2006 January 2006 December 2005 November 2005 October 2005 September 2005 August 2005 July 2005 June 2005 SearchPowered by Movable Type 3.33 Site design by Sekimori |